We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
-10.3%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.85B
AUM Growth
-$949M
Cap. Flow
-$393M
Cap. Flow %
-10.22%
Top 10 Hldgs %
10.07%
Holding
2,323
New
652
Increased
471
Reduced
539
Closed
577

Sector Composition

Rank Sector Weight
1 Technology 15.44%
2 Consumer Discretionary 14.53%
3 Healthcare 13.43%
4 Industrials 13.16%
5 Financials 12.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWLVW
1401
DELISTED
Twelve Seas Investment Company Warrant
TWLVW
$303K 0.01%
1,167,250
AGI icon
1402
Alamos Gold
AGI
$13.9B
$301K 0.01%
+83,570
New +$327K
IRMD icon
1403
iRadimed
IRMD
$1.18B
$300K 0.01%
12,247
-40,384
-77% -$1.09M
ORRF icon
1404
Orrstown Financial Services
ORRF
$838M
$300K 0.01%
16,483
-2,330
-12% -$49.4K
SPRO icon
1405
Spero Therapeutics
SPRO
$73M
$298K 0.01%
48,382
+34,666
+253% +$281K
CYBE
1406
DELISTED
Cyberoptics Corp
CYBE
$298K 0.01%
+16,926
New +$320K
MFAC.WS
1407
DELISTED
Megalith Financial Acquisition Corp. Warrants, each warrant exercisable for one share of Class A Com
MFAC.WS
$296K 0.01%
+740,000
New +$362K
BDN
1408
Brandywine Realty Trust
BDN
$554M
$295K 0.01%
+22,905
New +$324K
HPP
1409
Hudson Pacific Properties
HPP
$779M
$295K 0.01%
1,448
-15,317
-91% -$3.27M
SPWR
1410
DELISTED
SunPower Corporation Common Stock
SPWR
$295K 0.01%
+90,762
New +$377K
CFR icon
1411
Cullen/Frost Bankers
CFR
$10.2B
$293K 0.01%
3,333
-19,109
-85% -$1.86M
MLR icon
1412
Miller Industries
MLR
$619M
$293K 0.01%
10,870
-1,768
-14% -$46.7K
NSLR
1413
Neostellar Capital Corp
NSLR
$254M
$292K 0.01%
66,676
-120,240
-64% -$663K
AFH
1414
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$291K 0.01%
36,013
-30,332
-46% -$290K
CDTX
1415
DELISTED
Cidara Therapeutics
CDTX
$290K 0.01%
6,178
+2,104
+52% +$150K
CYD icon
1416
China Yuchai International
CYD
$1.78B
$288K 0.01%
+23,155
New +$333K
BIO icon
1417
Bio-Rad Laboratories Class A
BIO
$9.42B
$287K 0.01%
1,234
-3,533
-74% -$948K
WEYS icon
1418
Weyco Group
WEYS
$440M
$287K 0.01%
9,833
-8,391
-46% -$267K
FSTR icon
1419
Foster
FSTR
$432M
$285K 0.01%
+17,918
New +$334K
DCI icon
1420
Donaldson
DCI
$11.4B
$284K 0.01%
+6,540
New +$338K
EIDX
1421
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$284K 0.01%
20,658
-44,970
-69% -$567K
SLP icon
1422
Simulations Plus
SLP
$371M
$282K 0.01%
+14,146
New +$279K
LSEAW
1423
DELISTED
Landsea Homes Corporation Warrant
LSEAW
$281K 0.01%
670,000
MRKR icon
1424
Marker Therapeutics
MRKR
$18.7M
$281K 0.01%
+5,060
New +$369K
FND icon
1425
Floor & Decor
FND
$6.68B
$280K 0.01%
+10,811
New +$315K

Similar funds

Oxford Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Oxford Asset Management held 2,323 positions worth $3.85B, down 20% from $4.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Oxford Asset Management withdrew a net $393M in Q4 2018, closing 577 positions and reducing 539 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in Athenahealth, Inc. worth $69.9M.

  • Oxford Asset Management's largest Q4 2018 buy was Athenahealth, Inc.: 530,000 shares worth $69.9M.
  • Oxford Asset Management added most to Integrated Device Technology I in Q4 2018, an estimated $34.6M increase.
  • Oxford Asset Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $18.1M.
  • Oxford Asset Management fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $105M.
  • Oxford Asset Management's ten largest holdings make up 10% of its $3.85B portfolio in Q4 2018.
  • Oxford Asset Management opened 652 new positions and closed 577 in Q4 2018.
  • Oxford Asset Management's portfolio value fell 20% quarter-over-quarter to $3.85B.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.